MARALIXIBAT CHLORIDE | N214662 | MIRUM PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. et al v. Annora Pharma Private Limited et al 8 patentsANDA 220780maralixibat | D. Del. | 2025-12-19 | Active | — |
| D. Del. | 2025-12-19 | Active | — | |
Mirum Pharmaceuticals, Inc. et al v. Zenara Pharma Private Limited et al 8 patentsANDA 220917maralixibat | D. Del. | 2025-12-19 | Active | — |
Mirum Pharmaceuticals, Inc. et al v. Zydus Lifesciences Global FZE et al 8 patentsANDA 220669Maralixibat Chloride Solution, Oral | D. Del. | 2025-12-19 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 10512657 | Oct 26, 2032 | — | — | — | — | |
| 11229647 | Feb 12, 2040 | — | — | — | — | |
| 11229647 | Feb 12, 2040 | — | — | — | — | |
| 11229661 | Oct 26, 2032 | — | — | — | — | |
| 11260053 | May 26, 2031 | — | — | — | — | |
| 11260053 | May 26, 2031 | — | — | — | — | |
| 11376251 | Oct 26, 2032 | — | — | — | — | |
| 11376251 | Oct 26, 2032 | — | — | — | — | |
| 11497745 | Feb 12, 2040 | — | — | — | — | |
| 11497745 | Feb 12, 2040 | — | — | — | — | |
| 11918578 | Feb 12, 2040 | — | — | — | — | |
| 11918578 | Feb 12, 2040 | — | — | — | — | |
| 12599602 | Feb 12, 2040 | — | — | — | — | |
| 12599602 | Feb 12, 2040 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| I-938 | Mar 13, 2027 | < 1 year |
| NCE | Sep 29, 2026 | Expired |
| NPP | Mar 13, 2026 | Expired |
| ODE-379 | Sep 29, 2028 | Active |
| ODE-429 | Mar 13, 2030 | Active |
| ODE-471 | Mar 13, 2031 | Active |